This is a Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19

NCT05046548 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
400
Enrollment
OTHER_GOV
Sponsor class

Conditions

Interventions

Sponsor

Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products